Lauren Westafer, DO MPH MS Profile picture
May 18 11 tweets 4 min read Twitter logo Read on Twitter
Are you considering going down the investigator route 🤓 in EM? Then you probably want to know about K awards. Some highlights from our panel at #SAEM23 🧵
What are early career K awards?
⭐️ career development awards
⭐️focus on developing research skills to turn you into an independent investigator
✌️broad types: institutional (k12/kl2) and individual awards (eg k08,k23)

researchtraining.nih.gov/programs/caree… (2/x) Image
💵K awards fund you (mostly) to have time to do research, learn, and apply for grants.
⭐️commit to 75% research/25% clinical
➡️”funds” 75% research time (capped at 75-125k depending on institution)-ie institution on hook for salary cap gap
⬇️ 💵 for project (~25-40k/year) (4/)
Is a K award right for you?
⭐️answer is individual , some people may be ready to go straight to an R01 or similar award
⭐️needs to fill gap in knowledge/skills to advance in research
⭐️goal to become independently funded researcher (5/)
How do you get a K award?
Lots of different paths, some of our common themes were
⭐️mentorship
⭐️institution
⭐️prelim pubs/data
⭐️protected time
⭐️children/family
⭐️rejection
⭐️reluctance
⭐️fellowships/training
⭐️”atypical” paths
⭐️finding your niche (6/)
Mentorship is key
✅ For K awards,a “mentor” must be someone with individual NIH funding
✅They don’t get salary support for their mentoring so need to believe in mentorship and growing academic researchers
✅should have a shared specialization in trainee area of research
(7/) ImageImage
Institutional support
⭐️b/c a Ks cost dept (salary cap gap) they must be on board and “write” a powerful letter of support
⭐️find a place that values growing EM research. peers can make you better (eg @emschoenfeld prompted me to apply for K12 & hooked me up w/great mentor (8/) Image
Protected (“academic”) time is important. It’s how you get and maintain grants and get research done. It’s helpful if you have some BEFORE you get a K to get the K (a research fellowship or some sweet deal) (/9)
Preliminary data and collaboration is important. Shows your project is feasible and that your team will give you adequate support. Building networks and collaborations can never start too early (/10) Image
⭐️Rejection. Embrace it. It will happen and it can make you better. Use the feedback
⭐️look at lots of funded Ks. The more you read, the more you will see the patters of success (hint: it’s a game) (/11)
There are TONS of websites with rich resources and FAQs about Ks. About timelines (example) ctsi.wakehealth.edu/service/k-awar… (/12)

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Lauren Westafer, DO MPH MS

Lauren Westafer, DO MPH MS Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @LWestafer

May 18
Navigating the binary gender paradigm - experiences of trans 🏳️‍⚧️ and gender expansive physicians at #SAEM23
⭐️Is there a problem?
⭐️What do we do?
From our work ➡️ jamanetwork.com/journals/jaman… @JarmanAF
🧵
We *know* trans/gender expansive patients don’t have same access or experience in healthcare. We *know* there’s stigma in healthcare delivery pubmed.ncbi.nlm.nih.gov/24184160/
It turns out that physicians also experience stigma and transphobia in the workplace jamanetwork.com/journals/jaman… (2/)
In fact, teaching in MEDICAL SCHOOLS / TRAINING conflates being trans/gender expansive with being mentally ill - not good for patients, also harmful for T/GE clinicians. Leads to burnout and ⬇️representation in medicine (3/) ImageImage
Read 12 tweets
Feb 2, 2021
At @BaystateEM we devoted a "Stats are fun" lecture to bamlanivimab in #COVID19 last week. We reviewed 2 RCTs in outpatients (BLAZE-1) on the topic - the consensus was, we should rename the series to "Stats are sneaky".. A 🧵 with some fun methodology pearls
First up - Chen et al nejm.org/doi/full/10.10… - This study came out first. It was a 4-arm RCT : 3 doses of bamlanivimab or placebo. Primary outcome: change in viral load on day 11.
⭐Not a patient-centered outcome. In fact, viral load (Ct) is of questionable significance (2/)
An important question in studies is-who got into the study? ⭐What did the population look like?
Here duration of symptoms to infusion is important- these people got the infusion quickly (~ 4 days after symptom onset).Often ED patients are further into the disease course (3/)
Read 17 tweets
Mar 10, 2020
I was supposed to deliver the @SAEMonline #NERDS20 Keynote. Bummed it's canceled due to #COVID19, b/c it's one of my favorite topics...knowledge translation (and the impact of the digital era on KT). KT seems simple-knowing what the evidence-based approach is...and doing it
Knowledge translation is hard because knowing what the right thing to do is really really really hard. #1 There is an insurmountable amount of literature
#2 Much of it is irrelevant (or garbage)
#3 Researchers are sneaky
#4 things change (#medicalreversal )
...but, the hard part of knowledge translation? DOING. for example, let's look at handwashing....we've only known it's helpful for a couple of centuries...but we are still TERRIBLE at it*+ ...

*pre-SARS-CoV-2 data
+I'm sure it still ain't ideal
Read 15 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(